December 4, 2018
Kite’s triel of CAR T cell therapy trial with high number of complete leukemia remission with 1 infusion
Gilead’s company Kite’s trial for KTE-X19, its chimeric antigen receptor T cell therapy for adults with ALL (leukemia), resulted in…